Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas

Hojabr Kakavand; Oana Crainic; Trina Lum; Sandra O’Toole; Richard Kefford; John F. Thompson; James S. Wilmott; Georgina V. Long; Richard A Scolyer

doi:10.1097/pat.0000000000000077

Related publications

Article2016

Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation

Carly Fox, Duncan Lambie, James S. Wilmott, Alex Pinder, Sandra Pavey, Kim‐Anh Lê Cao, Taner Akalın, Işıl Karaarslan, Fezal Özdemir, Richard A Scolyer, Miko Yamada, H. Peter Soyer, Helmut Schaider, Brian Gabrielli

Article2012

Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis

Ramin Shayan, Tara Karnezis, Rajmohan Murali, James S. Wilmott, Mark W. Ashton, G. Ian Taylor, John F. Thompson, Peter Hersey, Marc G. Achen, Richard A Scolyer, Steven A. Stacker

Article2016

BRAF (v600e) and NRAS (q61r/q61l) mutation analysis using immunohistochemistry: Implications for routine mutation testing of melanoma samples

Hojabr Kakavand, Trina Lum, James S. Wilmott, Elizabeth Smith, Sandra O’Toole, Georgina V. Long, Richard A Scolyer

Article2013

Melanomas of unknown primary have a mutation profile consistent with cutaneous sun‐exposed melanoma

Ken Dutton‐Regester, Hojabr Kakavand, Lauren G. Aoude, Mitchell Stark, Michael G. Gartside, Peter A. Johansson, Linda O’Connor, Cathy Lanagan, Varsha Tembe, Gulietta M. Pupo, Lauren E. Haydu, Christopher Schmidt, Graham J. Mann, John F. Thompson, Richard A Scolyer, Nicholas K. Hayward

Article2022

Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics

Robert V. Rawson, Eva R. Shteinman, Sameera Ansar, Ismael A. Vergara, John F. Thompson, Georgina V. Long, Richard A Scolyer, James S. Wilmott